The prevalence of Factor V Leiden, prothrombin G20210A, MTHFR C677T and MTHFR A1298C mutations in healthy Turkish population.
BACKGROUND
Factor V Leiden (FVL), prothrombin gene (PT G20210A) and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms are the main biomarkers used in the evaluation of tendency to venous thromboembolism. Our study aimed to investigate the distribution frequencies of these polymorphisms in healthy Turks living in the urban Yozgat region.


METHODS
This study included 90 blood donor candidates. All the donors were apparently healthy, and there was no family relationship between them. Mutations including FVL, PT G20210A, and MTHFR (C677T, A1298C) were investigated in all participants. Screening of polymorphisms was carried out using the SNaPshot® multiplex system.


RESULTS
There were 42 male and 48 female individuals with age range 17-78 years and mean age 47.5 ± 13.6 years. The heterozygous FVL mutation was noted in 17 (10 male and seven female) donors (19%). FVL mutation was more frequently encountered in males than in females (23.8% vs. 12.5%). The heterozygous PT G20210A mutation was observed in five (5.5%) of the 90 (three male, two female) donors. The prevalence of homozygous polymorphisms of MTHFR C677T was 8.8% and of MTHFR A1298C 13.3%. On the other hand, four of the 90 participants (4.4%) carried none of these polymorphisms.


CONCLUSIONS
This study showed that the prevalence of FVL, PT G20210A, MTHFR C677T and MTHFR A1298C polymorphisms is quite high, and the coexistence of FVL with other genotypes is not rare in a healthy Turkish population living in the Yozgat region. Of course, further detailed studies should be performed to support these findings. Hippokratia 2015; 19 (4): 309-313.
Department of Cardiovascular Surgery, Bozok University School of Medicine, Yozgat, Turkey.
M
M
Ekim
Department of Cardiovascular Surgery, Bozok University School of Medicine, Yozgat, Turkey.
H
H
Ekim
Department of Cardiovascular Surgery, Bozok University School of Medicine, Yozgat, Turkey.
Y K
YK
Yılmaz
Factor V Leiden; MTHFR; Prothrombin G20210A; polymorphism
Thromb J. 2015 Nov 10;13:35
26557789
Turk J Haematol. 2011 Sep 5;28(3):241-2
27264377
Turk J Haematol. 2009 Mar 5;26(1):9-11
27265101
J Appl Genet. 2013 Nov;54(4):441-446
23959593
Circulation. 2003 Jun 17;107(23 Suppl 1):I9-16
12814980
Heart Vessels. 2004 Jul;19(4):164-6
15278388
Cell Biochem Funct. 2005 Jan-Feb;23(1):51-4
15386535
Intern Med. 2011;50(1):17-21
21212568
Mediterr J Hematol Infect Dis. 2011;3:e2011037
22224194
Clin Appl Thromb Hemost. 2009 Oct;15(5):529-34
18840629
J Pak Med Assoc. 2015 Nov;65(11):1169-72
26564286
Am J Hematol. 2004 May;76(1):85-7
15114606
CMAJ. 1996 Aug 1;155(3):285-9
8705907
Hematol Rep. 2014 Apr 22;6(2):5321
25013715
Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):40-4
21733936
Am J Med Genet. 1999 Oct 8;86(4):380-4
10494095
Clin Appl Thromb Hemost. 2000 Apr;6(2):104-7
10775032
Angiology. 2006 Mar-Apr;57(2):193-6
16518527
J Thromb Thrombolysis. 2012 Oct;34(3):383-7
22528331
Blood. 1996 Nov 15;88(10):3698-703
8916933
Blood Cells Mol Dis. 2001 Mar-Apr;27(2):362-7
11259157
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004-8
8430067
Am J Hematol. 1998 Jul;58(3):249
9662283
Biochemistry. 2005 Oct 4;44(39):13082-90
16185076
Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E87-94
21078611
Clin Appl Thromb Hemost. 2007 Apr;13(2):166-71
17456626